https://www.thebodypro.com/author/sony-salzman

Latest by Sony Salzman

Various Road Closed signs
Research

Test-and-Treat for Hepatitis C: What Are the Obstacles?

A series of studies aim to determine whether test-and-treat strategies can be implemented for people with hepatitis C, much like programs for people living with HIV.

young man looking at pill before taking it
News

FDA Approves Descovy for PrEP, but Only for Cisgender Men and Transgender Women

The FDA approved the fixed-dose combination of emtricitabine and tenofovir alafenamide for PrEP, but advocates hope to see more research on the HIV prevention drug's efficacy for receptive vaginal sex for cisgender women and transgender men.

Doctors from HIVMA and IDSA on Capitol Hill
Conference Coverage

Doctors Meet With Congressional Staff to Push for 'Ending the HIV Epidemic' Budget

At IDWeek in Washington, D.C., leading infectious disease doctors and researchers met with U.S. Congress leadership to discuss HIV prevention, treatment, and care policy.

Washington DC at sunset, including Washington Monument
Conference Coverage

IDWeek 2019: What to Expect at This Year's Conference

We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.

Prison Cells
News

Strong Peer Networks in Prison Boost Overall Health, Study Finds

But other research links prisons themselves to mental health challenges and infectious disease outbreaks.

scientists working in a lab
News

'No Single Gay Gene': Major Study Unpacks the Complex Genetic Underpinnings of Same-Sex Behavior

"Genetics is less than half the story for sexual behavior, but it's still a contributing factor."

nurse preparing vaccine
News

The First In-Human Chlamydia Vaccine Trial Shows Positive Immune Response

A chlamydia infection makes HIV acquisition more likely.

Jared Baeten
Conference Coverage

What Does the HOPE Study Say About the Future of the Vaginal Ring for HIV Prevention?

The results were less favorable than expected, but experts -- and women who participated in the trial -- would like to see this prevention tool approved for use.

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference
Conference Coverage

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.